Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo.
Recent epidemiological evidence has linked hypoxia with the development of Alzheimer disease (AD). A number of in vitro and in vivo studies have reported that hypoxia can induce amyloid-β peptide accumulation through various molecular mechanisms including the up-regulation of the amyloid-β precursor...
Main Authors: | Alberto Serrano-Pozo, Manuel A Sánchez-García, Antonio Heras-Garvín, Rosana March-Díaz, Victoria Navarro, Marisa Vizuete, José López-Barneo, Javier Vitorica, Alberto Pascual |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5242476?pdf=render |
Similar Items
-
Correction: Acute and Chronic Sustained Hypoxia Do Not Substantially Regulate Amyloid-β Peptide Generation In Vivo.
by: PLOS ONE Staff
Published: (2017-01-01) -
In vivo induction of membrane damage by β-amyloid peptide oligomers
by: Carl Julien, et al.
Published: (2018-11-01) -
Disruption of amyloid plaques integrity affects the soluble oligomers content from Alzheimer disease brains.
by: Sebastian Jimenez, et al.
Published: (2014-01-01) -
Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-β peptide levels in vivo
by: Veronica Hirsch-Reinshagen, et al.
Published: (2007-04-01) -
Roles of Heparan Sulfate in Amyloid-β Pathology and Hypoxia
by: Hjertström, Elina
Published: (2011)